Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:818781rdf:typepubmed:Citationlld:pubmed
pubmed-article:818781lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:818781lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:818781lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:818781pubmed:issue12lld:pubmed
pubmed-article:818781pubmed:dateCreated1976-8-2lld:pubmed
pubmed-article:818781pubmed:abstractTextCyclophosphamide was applied i.p. in the dose of 100 mg kg-1 to rats. After one, two, three, and seven days the animals were killed and in the collected heparinized blood the incorporation of o-phosphate 32P in erythrocytes was determined in vitro at 37 degrees C and in 35 minutes. Decreased incorporation in animals with Cyclophosphamide indicated, compared with the control, disturbed metabolism of phosphate. The method can be applied as a criterion of secondary toxic effects in the treatment of cancerostatics of alkylation type.lld:pubmed
pubmed-article:818781pubmed:languageczelld:pubmed
pubmed-article:818781pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:818781pubmed:citationSubsetIMlld:pubmed
pubmed-article:818781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:818781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:818781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:818781pubmed:statusMEDLINElld:pubmed
pubmed-article:818781pubmed:monthDeclld:pubmed
pubmed-article:818781pubmed:issn0375-8427lld:pubmed
pubmed-article:818781pubmed:authorpubmed-author:GrahamGGlld:pubmed
pubmed-article:818781pubmed:authorpubmed-author:ProksováMMlld:pubmed
pubmed-article:818781pubmed:authorpubmed-author:ProkesJJlld:pubmed
pubmed-article:818781pubmed:authorpubmed-author:VulterinKKlld:pubmed
pubmed-article:818781pubmed:authorpubmed-author:SromováSSlld:pubmed
pubmed-article:818781pubmed:issnTypePrintlld:pubmed
pubmed-article:818781pubmed:volume20lld:pubmed
pubmed-article:818781pubmed:ownerNLMlld:pubmed
pubmed-article:818781pubmed:authorsCompleteYlld:pubmed
pubmed-article:818781pubmed:pagination755-61lld:pubmed
pubmed-article:818781pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-A...lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-C...lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-E...lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-R...lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-P...lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-F...lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-C...lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-P...lld:pubmed
pubmed-article:818781pubmed:meshHeadingpubmed-meshheading:818781-C...lld:pubmed
pubmed-article:818781pubmed:year1975lld:pubmed
pubmed-article:818781pubmed:articleTitle[Effect of cyclophosphamide on themetabolism of erythrocytes].lld:pubmed
pubmed-article:818781pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:818781pubmed:publicationTypeEnglish Abstractlld:pubmed